Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell TransplantRuihao Huang, Xi Zhang, Ting Chen et al.|JAMA Oncology|2023Cited by 53
Integrin alphavbeta3 enhances β-catenin signaling in acute myeloid leukemia harboring Fms-like tyrosine kinase-3 internal tandem duplication mutations: implications for microenvironment influence on sorafenib sensitivityHai Yi, Peiyan Kong|Oncotarget|2016Cited by 44
Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-GenzymeLu Wang, Lidan Zhu, Jia Liu et al.|Annals of Hematology|2023Cited by 11
Efficacy and toxicity of <scp>CLAG</scp> combined with pegylated liposomal doxorubicin in the treatment of refractory or relapsed acute myeloid leukemiaHan Yao, Xi Zhang, Cheng Zhang et al.|Cancer Medicine|2023Cited by 10
Donor-derived CD19 CAR-T Cells versus Chemotherapy Plus Donor Lymphocyte Infusion for Treatment of Recurrent CD19-positive B-ALL After Allogeneic Hematopoietic Stem Cell TransplantationXu Tan, Shifeng Lou, Xiaoqi Wang et al.|Current Medical Science|2023Cited by 8